SEARCH BUTTON
8 results with word "Ana Belén Cuenca" en Actualidad

NEWS

IQS Researcher Wei W. Chen Honoured by RSEQ and Lilly

Wei Wen Chen, a PhD student at IQS and IQAC-CSIC, was one of three researchers who was honoured with an award at the 21st edition of the Research Awards for PhD Students organized by the Spanish Royal Society of Chemistry (RSEQ) and the pharmaceutical company Lilly.

First Edition of the ChemBioEng IQS Talks

IQS presented the first ever edition of ChemBioEng IQS Talks in academic year 2022-23. It involves a series of conferences held with internationally renowned researchers in the areas of Chemistry, Bioengineering, and Engineering.

Research Groups led by women

Two female IQS researchers and professors lead two research groups at the university. They are Dr Ana Belén Cuenca, coordinator of the CISOL group, and Dr Meritxell Sáez, coordinator of the ADAMIQS group.

New Recognition for the Quality of IQS Research Groups

IQS is pleased to share the recognition given by AGAUR to the research groups that make up the teaching and research staff at our school, enabling us to affirm that IQS research is extensive and consolidated.

Click and Bioorthogonal Chemistry

Various IQS researchers are using winning methodologies from the 2022 Nobel Prize in Chemistry in their research in the fields of biomedicine, nanotechnology, and the search for new drugs.

IQS Hosts the MedChem 2022 European Conference

A fantastic success both in terms of attendees and content, IQS hosted and sponsored the 11th meeting of the Paul-Ehrlich Euro-PhD Network, part of the MedChem 2022 Conference.

New Synthesis Challenges. BISiboNds Project

Researchers from IQS and IQAC are working together on the development of new synthetic methodologies where they explore the combined use of catalytic systems with the great versatility of chemical elements such as Boron, Iodine and Silicon.

Photosensitive Targeted Nanocarriers for Selective Delivery of Photodynamic Therapy

Dr Elena de las Heras recently defended her doctoral thesis at IQS, in which she has designed and developed new photo-immuno-chemo-nanotransporters, which have shown high photodynamic activity against tumour cells and are effective and safe for the photodynamic delivery of doxorubicin on demand.
1